ES2083542T3 - Derivado del acido tienil-2-glicidico, su procedimiento de preparacion, y su utilizacion como intermediario de sintesis. - Google Patents

Derivado del acido tienil-2-glicidico, su procedimiento de preparacion, y su utilizacion como intermediario de sintesis.

Info

Publication number
ES2083542T3
ES2083542T3 ES91401833T ES91401833T ES2083542T3 ES 2083542 T3 ES2083542 T3 ES 2083542T3 ES 91401833 T ES91401833 T ES 91401833T ES 91401833 T ES91401833 T ES 91401833T ES 2083542 T3 ES2083542 T3 ES 2083542T3
Authority
ES
Spain
Prior art keywords
derived
glicidic
tienil
acid
preparation procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91401833T
Other languages
English (en)
Inventor
Andre Bousquet
Serge Calet
Alain Heymes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of ES2083542T3 publication Critical patent/ES2083542T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

LA INVENCION SE REFIERE AL TIENIL-2GLICIDATO DE ISOPROPILO DE FORMULA: OBTENIDO POR REACCION DEL TIENIL-2 CARBOXALDEHIDO CON UN HALOACETATO DE ISOPROPILO. SE UTILIZA COMO INTERMEDIARIO DE SINTESIS EN LA PREPARACION DE LA TIENIL-2 ACETALDOXIMA Y DE MEDICAMENTOS DERIVADOS DE TIENO/3, 2-C/ PIRIDINA.
ES91401833T 1990-07-04 1991-07-03 Derivado del acido tienil-2-glicidico, su procedimiento de preparacion, y su utilizacion como intermediario de sintesis. Expired - Lifetime ES2083542T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9008482A FR2664276B1 (fr) 1990-07-04 1990-07-04 Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.

Publications (1)

Publication Number Publication Date
ES2083542T3 true ES2083542T3 (es) 1996-04-16

Family

ID=9398353

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91401833T Expired - Lifetime ES2083542T3 (es) 1990-07-04 1991-07-03 Derivado del acido tienil-2-glicidico, su procedimiento de preparacion, y su utilizacion como intermediario de sintesis.

Country Status (13)

Country Link
US (1) US5132435A (es)
EP (1) EP0465358B1 (es)
JP (1) JP3055819B2 (es)
AT (1) ATE133950T1 (es)
CA (1) CA2046126C (es)
DE (1) DE69116943T2 (es)
DK (1) DK0465358T3 (es)
ES (1) ES2083542T3 (es)
FR (1) FR2664276B1 (es)
GR (1) GR3018947T3 (es)
HU (1) HU213397B (es)
IE (1) IE73223B1 (es)
PT (1) PT98181B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013666A (en) * 1996-07-02 2000-01-11 Sang Sup Jew Oxirane carboxylic acid derivative and its manufacturing method
US6043368A (en) * 1996-09-04 2000-03-28 Poli Industria Chimica, S.P.A. Method of making thieno-pyridine derivatives
FR2760456B1 (fr) * 1997-03-05 2000-05-12 Sanofi Sa Procede de preparation de derives de 2-thienyl-ethylamine
FR2769313B1 (fr) * 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
FR2779726B1 (fr) * 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
ES2278010T3 (es) * 2001-01-24 2007-08-01 Cadila Healthcare Limited Procedimiento de preparacion de clopidrogel.
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
JP2005514387A (ja) * 2001-12-18 2005-05-19 テバ ファーマシューティカル インダストリーズ リミティド クロピドグレル硫酸水素塩の多型体
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
US20060100231A1 (en) * 2003-03-10 2006-05-11 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
WO2004098593A1 (en) * 2003-05-05 2004-11-18 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate composition
ATE455778T1 (de) 2003-11-03 2010-02-15 Cadila Healthcare Ltd Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
EP1772455A3 (en) * 2004-03-05 2007-06-27 IPCA Laboratories Limited Industrial process for preparation a polmorph of clopidogrel hydrogen sulphate
EP1704152A2 (en) * 2004-09-21 2006-09-27 Teva Pharmaceutical Industries Ltd Crystalline clopidogrel hydrobromide and processes for preparation thereof
US20060223845A1 (en) * 2005-02-24 2006-10-05 Eran Turgeman Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
US8063217B2 (en) * 2005-07-12 2011-11-22 Rpg Life Sciences Limited Process for preparation of methyl-(+)-(S)-alpha-(2-chlorophenyl)-6, 7-dihydrothieno[3,2-C]pyridine-5(4H) -acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
US20080311636A1 (en) * 2005-09-02 2008-12-18 Daiichi Fine Chemical Co., Ltd. Method for Producing Optically Active Alpha-Hydroxycarboxylic Acid
WO2007125544A2 (en) * 2006-04-27 2007-11-08 Ind-Swift Laboratories Limited Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate
EP2064217B1 (en) 2006-09-04 2011-01-19 Ranbaxy Laboratories Limited An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts
KR100978498B1 (ko) * 2006-10-17 2010-08-30 최중헌 클로피도그렐 황산수소염의 제조방법
KR101365689B1 (ko) * 2006-10-27 2014-02-24 (주)유케이케미팜 (ｒ)-2-히드록시-2-(클로로페닐)초산 메틸 에스테르황산염의 제조방법
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
BRPI0803101A2 (pt) * 2007-04-18 2014-04-22 Teva Pharma Processos melhores para preparação de clopidogrel
CN102186858A (zh) * 2008-10-24 2011-09-14 桑多斯股份公司 制备s-氯吡格雷的方法
CN101585842B (zh) * 2009-07-13 2011-07-20 北京赛科药业有限责任公司 氯吡格雷中杂质b的研究及控制方法
CN101987854A (zh) * 2009-08-04 2011-03-23 北京万全阳光医学技术有限公司 一种氯吡格雷及其盐的制备方法
WO2012123958A1 (en) 2011-02-14 2012-09-20 Cadila Healthcare Limited Highly pure salts of clopidogrel free of genotoxic impurities
CN102250114B (zh) * 2011-04-27 2014-02-26 青岛黄海制药有限责任公司 一种氯吡格雷及其硫酸盐的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6047274B2 (ja) * 1976-07-07 1985-10-21 株式会社三和化学研究所 新規のチエノ〔３，２−ｆ〕モルファン誘導体及びその塩並びにこれ等の製法
FR2508456A1 (fr) * 1981-06-30 1982-12-31 Sanofi Sa Procede de preparation de (thienyl-2)-2 ethylamines et (thienyl-3)-2 ethylamines
JPS62103087A (ja) * 1985-10-28 1987-05-13 Toyo Pharma- Kk ５−（２−クロロベンジル）−４，５，６，７−テトラヒドロチエノ〔３，２−ｃ〕ピリジン又はその塩の製造方法

Also Published As

Publication number Publication date
PT98181A (pt) 1993-08-31
EP0465358B1 (fr) 1996-02-07
US5132435A (en) 1992-07-21
IE73223B1 (en) 1997-05-07
HU213397B (en) 1997-06-30
DK0465358T3 (da) 1996-05-28
ATE133950T1 (de) 1996-02-15
CA2046126A1 (en) 1992-01-05
CA2046126C (en) 2001-11-20
PT98181B (pt) 1998-12-31
HU912250D0 (en) 1991-12-30
JPH04261174A (ja) 1992-09-17
EP0465358A1 (fr) 1992-01-08
DE69116943T2 (de) 1996-09-19
DE69116943D1 (de) 1996-03-21
GR3018947T3 (en) 1996-05-31
IE912328A1 (en) 1992-01-15
FR2664276B1 (fr) 1992-10-23
JP3055819B2 (ja) 2000-06-26
FR2664276A1 (fr) 1992-01-10
HUT61754A (en) 1993-03-01

Similar Documents

Publication Publication Date Title
ES2083542T3 (es) Derivado del acido tienil-2-glicidico, su procedimiento de preparacion, y su utilizacion como intermediario de sintesis.
HUT61556A (en) New process for producing n-phenylacetic acid derivative of tetrahydrothieno/3,2-c/pyridine
LV11683A (lv) Fenilacetoksitienopiridinu un to starpproduktu - alfa-bromfeniletikskabes atvasinajumu iegusanas panemiens
ES472002A1 (es) Procedimiento para la preparacion de acidos 1,2-dihidro-3h-pirrolo (1,2-a)-pirrol-1-carboxilicos 5 sustituidos.
AR217668A1 (es) Procedimiento de preparacion de derivados de tetrahidro-4,5,6,7-tieno-(2,3-c)-y-(3,2-c)-piridinas,utilizables como medicamentos
DE3263882D1 (en) 11-deoxoglycyrrhetinic acid hydrogen maleate, process for its production, and its use as a medicine
SE7902866L (sv) 3-0-(beta-d-glukuronopyranosyl)-sojasapogenol b
JPS5419969A (en) Proline derivative and its preparation
SE7907986L (sv) Sett att framstella 3alfa,7beta-dihydroxicholansyra
ES2068980T3 (es) Procedimiento para la preparacion de diterciobutoxidiacetoxisilano.
ES2100657T3 (es) Preparacion de 1-amino-1-cianamido-2,2-dicianoetileno, sal sodica.
JPS5414295A (en) Sample observing apparatus
JPS52155690A (en) Preparation of desulfated mucopolysaccharide
JPS53130647A (en) Preparation of 1-aminoanthraquinone
JPS52153915A (en) Preparation of alpha-amino-delta-hydroxyvaleric acid
JPS5414931A (en) Preparation of n-benzylglycine
DE2961506D1 (en) N-cyclohexyl-n-methoxy-acetoacetamide, process for its preparation and its use to prepare o-methyl-n-cyclohexyl-2,5-dimethyl-furane-3-hydroxamic acid
JPS543021A (en) Novel derivative of glutamic acid and its preparation
ES2003782A6 (es) Procedimiento para la obtencion de un compuesto derivado del acido flufenamico
JPS5411298A (en) Preparation of 3-heterocyclic thiomethylcephalosporins
JPS545985A (en) Preparation of 5-fluorouracil
ES2068410T3 (es) Procedimiento para la preparacion de acilales.
GB2000778A (en) Preparation of tetramisole intermediate
JPS53137374A (en) Belt type power transmitting mechanism
JPS5262859A (en) Articulation mechanism of industrial robbot

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 465358

Country of ref document: ES